Jedlicka P - Search Results

1

KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma.

Sobral LM, Hicks HM, Parrish JK, McCann TS, Hsieh J, Goodspeed A, Costello JC, Black JC, Jedlicka P. Sobral LM, et al. Among authors: jedlicka p. Mol Oncol. 2020 Oct;14(10):2471-2486. doi: 10.1002/1878-0261.12769. Epub 2020 Aug 5. Mol Oncol. 2020. PMID: 32697014 Free PMC article.

2

A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.

McKinsey EL, Parrish JK, Irwin AE, Niemeyer BF, Kern HB, Birks DK, Jedlicka P. McKinsey EL, et al. Among authors: jedlicka p. Oncogene. 2011 Dec 8;30(49):4910-20. doi: 10.1038/onc.2011.197. Epub 2011 Jun 6. Oncogene. 2011. PMID: 21643012 Free PMC article.

3

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

Kern HB, Niemeyer BF, Parrish JK, Kerr CA, Yaghi NK, Prescott JD, Gutierrez-Hartmann A, Jedlicka P. Kern HB, et al. Among authors: jedlicka p. DNA Cell Biol. 2012 Aug;31(8):1403-11. doi: 10.1089/dna.2011.1469. Epub 2012 May 3. DNA Cell Biol. 2012. PMID: 22553926 Free PMC article.

4

EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P, Ford HL. Robin TP, et al. Among authors: jedlicka p. Mol Cancer Res. 2012 Aug;10(8):1098-108. doi: 10.1158/1541-7786.MCR-12-0086. Epub 2012 Jun 20. Mol Cancer Res. 2012. PMID: 22723308 Free PMC article.

5

The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma.

Parrish JK, Sechler M, Winn RA, Jedlicka P. Parrish JK, et al. Among authors: jedlicka p. Oncogene. 2015 Jan 8;34(2):257-62. doi: 10.1038/onc.2013.541. Epub 2013 Dec 23. Oncogene. 2015. PMID: 24362521 Free PMC article.

6

Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.

Wang CA, Drasin D, Pham C, Jedlicka P, Zaberezhnyy V, Guney M, Li H, Nemenoff R, Costello JC, Tan AC, Ford HL. Wang CA, et al. Among authors: jedlicka p. Cancer Res. 2014 Dec 15;74(24):7357-70. doi: 10.1158/0008-5472.CAN-14-0666. Epub 2014 Oct 27. Cancer Res. 2014. PMID: 25348955 Free PMC article.

7

Variable expression of PIK3R3 and PTEN in Ewing Sarcoma impacts oncogenic phenotypes.

Niemeyer BF, Parrish JK, Spoelstra NS, Joyal T, Richer JK, Jedlicka P. Niemeyer BF, et al. Among authors: jedlicka p. PLoS One. 2015 Jan 20;10(1):e0116895. doi: 10.1371/journal.pone.0116895. eCollection 2015. PLoS One. 2015. PMID: 25603314 Free PMC article.

8

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.

Sechler M, Parrish JK, Birks DK, Jedlicka P. Sechler M, et al. Among authors: jedlicka p. Oncogene. 2017 Jul 20;36(29):4150-4160. doi: 10.1038/onc.2017.44. Epub 2017 Mar 20. Oncogene. 2017. PMID: 28319067 Free PMC article.

9

MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.

Moore C, Parrish JK, Jedlicka P. Moore C, et al. Among authors: jedlicka p. PLoS One. 2017 May 18;12(5):e0178028. doi: 10.1371/journal.pone.0178028. eCollection 2017. PLoS One. 2017. PMID: 28542597 Free PMC article.

10

The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers.

Jedlicka P. Jedlicka P. Expert Opin Ther Targets. 2017 Nov;21(11):997-999. doi: 10.1080/14728222.2017.1391791. Epub 2017 Oct 13. Expert Opin Ther Targets. 2017. PMID: 29022407 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters